These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2370051)

  • 41. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
    Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
    Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
    [No Abstract]   [Full Text] [Related]  

  • 42. High incidence of acute infantile spinal atrophy in Hungary.
    Czeizel A
    Hum Genet; 1991 Mar; 86(5):539. PubMed ID: 2016096
    [No Abstract]   [Full Text] [Related]  

  • 43. Infantile spinal muscular atrophy (SMA) and multiple congenital bone fractures in sibs: a lethal new syndrome.
    Borochowitz Z; Glick B; Blazer S
    J Med Genet; 1991 May; 28(5):345-8. PubMed ID: 1865475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy.
    Arkblad E; Tulinius M; Kroksmark AK; Henricsson M; Darin N
    Acta Paediatr; 2009 May; 98(5):865-72. PubMed ID: 19154529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Werdnig-Hoffmann disease in a Nigerian infant.
    Pelleboer RA; Maaswinkel-Mooy PD; Gelderen HH
    Trop Geogr Med; 1989 Jul; 41(3):282-4. PubMed ID: 2595812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease Burden in Children With Spinal Muscular Atrophy: Results From a Large Cross-Sectional Study.
    Rosero S; Weinstein J; Seabury J; Zizzi C; Wagner E; Varma A; Heatwole J; Alexandrou D; Ms ND; Johnson BA; Heatwole C
    J Child Neurol; 2023 Feb; 38(1-2):52-63. PubMed ID: 36537125
    [No Abstract]   [Full Text] [Related]  

  • 47. Coexistence of Spinal Muscular Atrophy Type 1 and Factor X1 Deficiency.
    Kaya G; Bahadir A; Acar Arslan E
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):115-116. PubMed ID: 33560085
    [No Abstract]   [Full Text] [Related]  

  • 48. [Heart involvement in progressive spinal muscular atrophy. A review of the literature and case histories in childhood].
    Distefano G; Sciacca P; Parisi MG; Parano E; Smilari P; Marletta M; Fiumara A
    Pediatr Med Chir; 1994; 16(2):125-8. PubMed ID: 8078785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene replacement therapy for spinal muscular atrophy unmasking occult hepatitis C in a pediatric patient.
    Lakhotia A; Turek G; Green J; Khan M
    Muscle Nerve; 2022 Jan; 65(1):E2-E3. PubMed ID: 34644404
    [No Abstract]   [Full Text] [Related]  

  • 51. Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q.
    Melki J; Abdelhak S; Sheth P; Bachelot MF; Burlet P; Marcadet A; Aicardi J; Barois A; Carriere JP; Fardeau M
    Nature; 1990 Apr; 344(6268):767-8. PubMed ID: 1970420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].
    Spiegel R; Hagmann A; Boltshauser E; Moser H
    Schweiz Med Wochenschr; 1996 May; 126(21):907-14. PubMed ID: 8693311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of spinal muscular atrophy in European countries: A call to action.
    Vázquez-Costa JF; Martínez-Moreno M; Madruga-Garrido M; Munell F; Nascimento A; Pitarch-Castellano I; Pascual-Pascual SI; Povedano M; Cattinari MG
    Eur J Neurol; 2022 Nov; 29(11):3475-3477. PubMed ID: 35971869
    [No Abstract]   [Full Text] [Related]  

  • 54. [SMN1 Gene Point Mutations in Type I-IV Proximal Spinal Muscular Atrophy Patients with a Single Copy of SMN1].
    Genetika; 2015 Sep; 51(9):1075-82. PubMed ID: 26606804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Spinal muscular atrophy: frequent cause of congenital hypotonia in Morocco].
    Sbiti A; Ratbi I; Kriouile Y; Sefiani A
    Arch Pediatr; 2011 Dec; 18(12):1261-4. PubMed ID: 22041598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe spinal muscular atrophy variant associated with congenital bone fractures.
    Felderhoff-Mueser U; Grohmann K; Harder A; Stadelmann C; Zerres K; Bührer C; Obladen M
    J Child Neurol; 2002 Sep; 17(9):718-21. PubMed ID: 12503654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hereditary factors in infantile progressive muscular atrophy; study of 112 cases in 70 families.
    BRANDT S
    Am J Dis Child (1911); 1949 Aug; 78(2):226-36. PubMed ID: 18135521
    [No Abstract]   [Full Text] [Related]  

  • 59. [Beyond type I spinal atrophy].
    Mastella C
    Assist Inferm Ric; 1999; 18(4):240-6. PubMed ID: 10833298
    [No Abstract]   [Full Text] [Related]  

  • 60. Infantile spinal progressive muscular atrophy in twins.
    POIRIER R; CORBET RC; BUCKWOLD AE
    Can Med Assoc J; 1951 Oct; 65(4):342-3. PubMed ID: 14879299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.